HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin 6-Mediated Endothelial Barrier Disturbances Can Be Attenuated by Blockade of the IL6 Receptor Expressed in Brain Microvascular Endothelial Cells.

Abstract
Compromised blood-brain barrier (BBB) by dysregulation of cellular junctions is a hallmark of many cerebrovascular disorders due to the pro-inflammatory cytokines action. Interleukin 6 (IL6) is implicated in inflammatory processes and in secondary brain injury after subarachnoid hemorrhage (SAH) but its role in the maintenance of cerebral endothelium still requires a precise elucidation. Although IL6 has been shown to exert pro-inflammatory action on brain microvascular endothelial cells (ECs), the expression of one of the IL6 receptors, the IL6R is controversially discussed. In attempt to reach more clarity in this issue, we present here an evident baseline expression of the IL6R in BBB endothelium in vivo and in an in vitro model of the BBB, the cEND cell line. A significantly increased expression of IL6R and its ligand was observed in BBB capillaries 2 days after experimental SAH in mice. In vitro, we saw IL6 administration resulting in an intracellular and extracellular elevation of IL6 protein, which was accompanied by a reduced expression of tight and adherens junctions, claudin-5, occludin, and vascular-endothelial (VE-) cadherin. By functional assays, we could demonstrate IL6-incubated brain ECs to lose their endothelial integrity that can be attenuated by inhibiting the IL6R. Blockade of the IL6R by a neutralizing antibody has reconstituted the intercellular junction expression to the control level and caused a restoration of the transendothelial electrical resistance of the cEND cell monolayer. Our findings add depth to the current understanding of the involvement of the endothelial IL6R in the loss of EC integrity implicating potential therapy options.
AuthorsKinga G Blecharz-Lang, Josephin Wagner, Alexa Fries, Melina Nieminen-Kelhä, Jörg Rösner, Ulf C Schneider, Peter Vajkoczy
JournalTranslational stroke research (Transl Stroke Res) Vol. 9 Issue 6 Pg. 631-642 (12 2018) ISSN: 1868-601X [Electronic] United States
PMID29429002 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens, CD
  • Cadherins
  • Cytokines
  • Interleukin-6
  • Occludin
  • Receptors, Interleukin-6
  • cadherin 5
Topics
  • Animals
  • Antibodies (pharmacology)
  • Antigens, CD (metabolism)
  • Blood-Brain Barrier (pathology)
  • Cadherins (metabolism)
  • Cell Line, Transformed
  • Cell Proliferation
  • Cytokines (metabolism)
  • Disease Models, Animal
  • Electric Impedance
  • Endothelial Cells (drug effects, metabolism)
  • Endothelium, Vascular (pathology)
  • Gene Expression Regulation (drug effects, physiology)
  • Interleukin-6 (immunology, metabolism, pharmacology)
  • Magnetic Resonance Imaging
  • Male
  • Mice
  • Occludin (metabolism)
  • Receptors, Interleukin-6 (genetics, metabolism)
  • Subarachnoid Hemorrhage (diagnostic imaging, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: